Effect of Ranolazine on Valvular Disease in Patients With Pacemakers — REIN-MR

Ischemic Mitral Regurgitation Clinical Trial

Official title:
Ranolazine Effects on Ischemic Mitral Regurgitation Severity in Patients With Cardiac Resynchronization Therapy

Status Enrolling by invitation

Clinical Trial Summary

The purpose of this study is to find out whether mitral regurgitation (or a leaky heart valve) caused by ischemic heart disease (decreased blood flow to heart muscle) will improve after administration of ranolazine.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Supportive Care

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01979965
Study type	Interventional
Source	University Cardiology
Contact
Status	Enrolling by invitation
Phase	Phase 4
Start date	November 2013
Completion date	September 2014

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04396379` - Epicardial Mitral Touch System for Mitral Insufficiency	N/A
Not yet recruiting	`NCT04106648` - Effect of Significant Ischemic Mitral Regurgitation on the Outcome of ST Segment Elevation Myocardial Infarction Patients Treated With Primary Percutaneous Coronary Intervention
Recruiting	`NCT05469165` - Serotonin Receptor Blockers in Ischemic Mitral Regurgitation	Phase 2
Suspended	`NCT04023058` - Stress Echo for Ischemic Mitral Valve Surgery	N/A